James William Langston
James William Langston
Clinical Professor of Neurology, Neuroscience and Pathology, Stanford
Verified email at
Cited by
Cited by
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
JW Langston, P Ballard, JW Tetrud, I Irwin
Science 219 (4587), 979-980, 1983
Rotenone, paraquat, and Parkinson’s disease
CM Tanner, F Kamel, GW Ross, JA Hoppin, SM Goldman, M Korell, ...
Environmental health perspectives 119 (6), 866-872, 2011
Parkinson disease in twins: an etiologic study
CM Tanner, R Ottman, SM Goldman, J Ellenberg, P Chan, R Mayeux, ...
Jama 281 (4), 341-346, 1999
Core assessment program for intracerebral transplantations (CAPIT)
JW Langston, H Widner, CG Goetz, D Brooks, S Fahn, T Freeman, ...
Movement disorders: official journal of the Movement Disorder Society 7 (1 …, 1992
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine exposure
JW Langston, LS Forno, J Tetrud, AG Reeves, JA Kaplan, D Karluk
Annals of Neurology: Official Journal of the american neurological …, 1999
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyrine (MPTP) in the squirrel monkey
JW Langston, LS Forno, CS Rebert, I Irwin
Brain research 292 (2), 390-394, 1984
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
AL McCormack, M Thiruchelvam, AB Manning-Bog, C Thiffault, ...
Neurobiology of disease 10 (2), 119-127, 2002
The Neurobehavioral Cognitive Status Examination: A brief but differentiated approach to cognitive assessment
RJ Kiernan, J Mueller, JW Langston, C Van Dyke
Annals of internal medicine 107 (4), 481-485, 1987
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
M Farrer, J Kachergus, L Forno, S Lincoln, DS Wang, M Hulihan, ...
Annals of Neurology: Official Journal of the American Neurological …, 2004
Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP): Seven cases
PA Ballard, JW Tetrud, JW Langston
Neurology 35 (7), 949-949, 1985
The effect of deprenyl (selegiline) on the natural history of Parkinson's disease
JW Tetrud, JW Langston
Science 245 (4917), 519-522, 1989
The Parkinson's complex: parkinsonism is just the tip of the iceberg
JW Langston
Annals of Neurology: Official Journal of the American Neurological …, 2006
Pargyline prevents MPTP-induced parkinsonism in primates
JW Langston, I Irwin, EB Langston, LS Forno
Science 225 (4669), 1480-1482, 1984
Aetiology of Parkinson's disease
DB Calne, JW Langston
The Lancet 322 (8365-8366), 1457-1459, 1983
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ...
Movement Disorders 32 (9), 1264-1310, 2017
Lewy bodies and parkinsonism in families with parkin mutations
M Farrer, P Chan, R Chen, L Tan, S Lincoln, D Hernandez, L Forno, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-l, 2, 3, 6-tetrahydropyridine (MPTP)
H Widner, J Tetrud, S Rehncrona, B Snow, P Brundin, B Gustavii, ...
New England Journal of Medicine 327 (22), 1556-1563, 1992
Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease
CB Do, JY Tung, E Dorfman, AK Kiefer, EM Drabant, U Francke, ...
PLoS genetics 7 (6), e1002141, 2011
Parkinson's disease in a chemist working with l-methyl-4-phenyl-l, 2, 5, 6-tetrahydropyridine.
JW Langston, PA Ballard Jr
New England Journal of Medicine 309 (5), 1983
1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra
JW Langston, I Irwin, EB Langston, LS Forno
Neuroscience letters 48 (1), 87-92, 1984
The system can't perform the operation now. Try again later.
Articles 1–20